Experience with interferon-gamma in the therapy of sexually transmitted viral infections


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Objective. To investigate the efficacy and safety of Ingaron (interferon-gamma) in the combined therapy of sexually transmitted viral infections (STVIs). Subjects and methods. The investigation included 26 patients diagnosed with anogenital herpetic infection (Subgroups 1A and IB) and 64 patients with anogenital (venereal) warts (Subgroups 2A, 2B, 2C, and 2D). Subgroup 1A received combined therapy with acyclovir and Ingaron; Subgroup IB took acyclovir only; Subgroup 2A had Ingaron in combination with cryodestruction; Subgroup 2B received cryodestruction; and Subgroup 2C took Ingaron in combination with destruction with Solcoderm; Subgroup 2D had destruction with Solcoderm. Results. Recurrent anogenital herpetic infection was absent in 92.9% of the patients receiving combined therapy with acyclovir and Ingaron and in 58.3% of those on acyclovir therapy. In patients with anogenital warts, the efficiency of combined therapy (Ingaron + cryodestruction; Ingaron + Solcoderm) exceeded that of therapy with cryodestruction only or with Solcoderm: 94.1, 93.3, 58.8, and 40.0%, respectively. During therapy, there were no serious adverse events or clinically significant changes in the general clinical and biochemical blood tests. Conclusion. The use of Ingaron in the combined therapy of viral STVIs demonstrates a high clinical efficacy and safety profile and assists in reducing the rate of recurrence.

全文:

受限制的访问

作者简介

Margarita Rakhmatulina

State Research Center-Bumasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: ra.marg@yandex.ru
MD, professor of the Department a dermatovenereology and cosmetology with a course of clinical laboratory diagnostics

Natalia Bolshenko

Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being; Moscow Regional Clinical Dermatovenereology Dispensary

PhD, the head researcher; The chief of the consultative-diagnostic department

参考

  1. Глобальная стратегия сектора здравоохранения по инфекциям, передаваемым половым путем 2016-2021 гг. ВОЗ; 2016. Available at: http://www.who.int/mediacentre/factsheets/fs110/ru/
  2. European guidelines for the management of genital herpes. 2017. Available at: https://www.iusti.org/regions/Europe/pdf/2017/2017EuropeanGuidelineForManagementOfGenitalHerpes061216.pdf
  3. Роговская C.A., Акопова E.C., Коган E.A. Совершенствование лечебнодиагностических подходов к ВПЧ-инфекции гениталий. Медицинский альманах. 2012; 5: 85-7.
  4. Рахматулина M.P., Болъшенко H.B., Куевда Д.А. Особенности клинического течения папилломавирусной инфекции в зависимости от генотипа и количественных показателей вирусов папилломы человека высокого онкогенного риска. Вестник дерматологии и венерологии. 2014; 3: 95-105.
  5. Handfield C., Kwock J., MacLeod A.S. Innate antiviral immunity in the skin. Trends Immunol. 2018; 39(4): 328-40.
  6. Shcheglovitova O.N., Boldyreva N. V., Sklyankina N.N., Babayants A.A., Frolova I.S. IFN-α, IFN-β, and IFN-γ have different effect on the production of proinflam-matory factors deposited in weibel-palade bodies of endothelial cells infected with herpes simplex virus type 1. Bull. Exp. Biol. Med. 2016; 161(2): 270-5.
  7. do Carmo Vasconcelos de Carvalho V., de Macedo J.L., de Lima C.A., da Conceigao Gomes de Lima М., de Andrade Heráclio S., Amorim M. et al. IFN-gamma and IL-12B polymorphisms in women with cervical intraepithellial neoplasia caused by human papillomavirus. Моl. Biol. Rep. 2012; 39(7): 7627-34.
  8. Merheb R., Abdel-Massih R.M., Кагат М. C. Immunomodulatory effect of natural and modified Citrus pectin on cytokine levels in the spleen of BALB/c mice. Int. J. Biol. Macromol. 2018; 121: 1-5.
  9. Povoa T.F., Oliveira E.R.A., Basilio-de-Oliveira C.A. Correction: peripheral organs of dengue fatal cases present strong pro-inflammatory response with participation of IFN-Gamma-, TNF-Alpha- and RANTES-producing cells. PLoS One. 2018; 13(3): e0195140.

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2018
##common.cookie##